|
Volumn 46, Issue 7, 2011, Pages 3158-3166
|
3-(1,3,4-Thiadiazole-2-yl)quinoline derivatives: Synthesis, characterization and anti-microbial activity
|
Author keywords
Anti microbial activity; Chloroquinoline 3 carboxaldehyde; Thiadiazole; Thiosemicarbazone
|
Indexed keywords
1 (2 CHLORO 8 METHYLCHLOROQUINOLIN 3 YL) 4 (2,5 DIFLUOROPHENYL)THIOSEMICARBAZIDE;
1 (2 CHLORO 8 METHYLCHLOROQUINOLIN 3 YL) 4 4 TOLYLTHIOSEMICARBAZIDE;
1 [(2 CHLORO 8 METHYLCHLOROQUINOLIN 3 YL)METHYLENE] 4 2 TOLYLTHIOSEMICARBAZIDE;
1 [(2 CHLORO 8 METHYLCHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOHEXYLTHIOSEMICARBAZIDE;
1 [(2 CHLORO 8 METHYLCHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOOCTYLTHIOSEMICARBAZIDE;
1 [(2 CHLORO 8 METHYLCHLOROQUINOLIN)METHYLENE] 4 CYCLOPENTYLTHIOSEMICARBAZIDE;
1 [(2 CHLORO 8 METHYLCHLOROQUINOLIN)METHYLENE]THIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 (2,5 DIFLUOROPHENYL)THIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 2 TOLYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 4 NITROPHENYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 4 TOLYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOHEXYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOOCTYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOPENTYLTHIOSEMICARBAZIDE;
1 [(2 CHLOROQUINOLIN 3 YL)METHYLENE]THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE) 4 (2,5 DIFLUOROPHENYL)THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 2 TOLYLTHIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 4 NITROPHENYLTHIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 4 TOLYLTHIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOHEXYL THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOOCTYL THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE] 4 CYCLOPENTYL THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE]THIOSEMICARBAZIDE;
1 [(2,8 DICHLOROQUINOLIN 3 YL)METHYLENE]THIOSEMICARBAZIDE DERIVATIVE;
3 (1,3,4 THIADIAZOLE 2 YL)QUINOLINE DERIVATIVE;
AMOXICILLIN;
QUINOLINE DERIVATIVE;
THIADIAZOLE DERIVATIVE;
THIOSEMICARBAZONE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIINFECTIVE AGENT;
QUINOLINOL DERIVATIVE;
ANIMAL CELL;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CHEMICAL STRUCTURE;
DRUG SYNTHESIS;
ELECTROSPRAY MASS SPECTROMETRY;
ESCHERICHIA COLI;
INFRARED SPECTROSCOPY;
MICROBIAL GROWTH;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
SALMONELLA TYPHIMURIUM;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PYOGENES;
ANIMAL;
CELL LINE;
CELL SURVIVAL;
CYTOLOGY;
DRUG EFFECTS;
GROWTH, DEVELOPMENT AND AGING;
HEART MUSCLE CELL;
MICROBIAL SENSITIVITY TEST;
SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;
SYNTHESIS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CELL LINE;
CELL SURVIVAL;
ESCHERICHIA COLI;
HYDROXYQUINOLINES;
MICROBIAL SENSITIVITY TESTS;
MYOCYTES, CARDIAC;
RATS;
SALMONELLA TYPHIMURIUM;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PYOGENES;
THIADIAZOLES;
THIOSEMICARBAZONES;
|
EID: 79957482244
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2011.04.013 Document Type: Article |
Times cited : (58)
|
References (31)
|